Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 15516846)

  • 1. Inflammatory bowel disease in Ashkenazi Jews: implications for familial colorectal cancer.
    Lynch HT; Brand RE; Locker GY
    Fam Cancer; 2004; 3(3-4):229-32. PubMed ID: 15516846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinogenesis in inflammatory bowel disease.
    Herszenyi L; Miheller P; Tulassay Z
    Dig Dis; 2007; 25(3):267-9. PubMed ID: 17827953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory bowel disease as a risk factor for colorectal cancer.
    Lukas M
    Dig Dis; 2010; 28(4-5):619-24. PubMed ID: 21088413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
    Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of Activated Cdc42 Kinase1 in Colitis and Colorectal Neoplasms.
    Lv C; Zhao X; Gu H; Huang L; Zhou S; Zhi F
    Med Sci Monit; 2016 Dec; 22():4794-4802. PubMed ID: 27926694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
    J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The histological diagnosis of dysplastic and neoplastic lesions in inflammatory bowel disease: a pathological perspective.
    Usaj S; Tarabar D; Cuk V; Cerovic S; Brajukovic G; Panisic M; Klem I; Eric Z
    Acta Chir Iugosl; 2004; 51(2):109-16. PubMed ID: 15771301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases.
    Itzkowitz SH; Harpaz N
    Gastroenterology; 2004 May; 126(6):1634-48. PubMed ID: 15168373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?
    Breynaert C; Vermeire S; Rutgeerts P; Van Assche G
    Acta Gastroenterol Belg; 2008; 71(4):367-72. PubMed ID: 19317276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic problems and advances in inflammatory bowel disease.
    Odze R
    Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.
    Sjöqvist U; Tribukait B; Ost A; Einarsson C; Oxelmark L; Löfberg R
    Anticancer Res; 2004; 24(5B):3121-7. PubMed ID: 15510599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk.
    Herszényi L; Barabás L; Miheller P; Tulassay Z
    Dig Dis; 2015; 33(1):52-7. PubMed ID: 25531497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
    Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulcerative colitis neoplasia is not associated with common inflammatory bowel disease single-nucleotide polymorphisms.
    Connelly TM; Berg AS; Harris LR; Brinton DL; Hegarty JP; Deiling SM; Stewart DB; Koltun WA
    Surgery; 2014 Aug; 156(2):253-62. PubMed ID: 24947639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in colorectal cancer incidence and mortality in the Israeli Jewish ethnic populations.
    Barchana M; Liphshitz I; Rozen P
    Fam Cancer; 2004; 3(3-4):207-14. PubMed ID: 15516843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carrier rate of APC I1307K is not increased in inflammatory bowel disease patients of Ashkenazi Jewish origin.
    Silverberg MS; Clelland C; Murphy JE; Steinhart AH; McLeod RS; Greenberg GR; Cohen Z; Siminovitch KA
    Hum Genet; 2001 Mar; 108(3):205-10. PubMed ID: 11354631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic factors and colorectal cancer in Ashkenazi Jews.
    Locker GY; Lynch HT
    Fam Cancer; 2004; 3(3-4):215-21. PubMed ID: 15516844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Premalignant and malignant changes in idiopathic inflammatory bowel disease].
    Knezević-Usaj S; Panisić M; Tarabar D; Cuk V; Brajuković G; Petrović M
    Acta Chir Iugosl; 2000; 47(1-2):43-50. PubMed ID: 10953365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.